An SGLT-2 inhibitor can be initiated for kidney protection above an eGFR > 20 ml/min per 1.73 m2; however, if further glucose lowering is required, adding another class of medications to optimize diabetes control is recommended.1 The gene discussed is SLC5A2; the disease is diabetes mellitus.